iMSC

BIOLOGICAL2 trials

Sponsors

Anhui Provincial Hospital, Ruijin Hospital

Conditions

Acute Graft-versus-Host DiseaseSteroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

Early Phase 1

A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Not yet recruitingNCT06949267

Ruijin HospitalAcute Graft-versus-Host Disease

Start: 2025-06-01End: 2028-03-31Target: 56Updated: 2025-04-29

Unknown Phase

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

RecruitingNCT06321198

Anhui Provincial HospitalSteroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

Start: 2024-02-10End: 2027-03-02Target: 12Updated: 2026-03-27